Seino Y, Yamazaki Y
Proc Jpn Acad Ser B Phys Biol Sci. 2025; 101(2):68-74.
PMID: 39924177
PMC: 11893219.
DOI: 10.2183/pjab.101.009.
Ramasamy I
J Clin Med. 2024; 13(5).
PMID: 38546831
PMC: 10932430.
DOI: 10.3390/jcm13051347.
Folli F, Finzi G, Manfrini R, Galli A, Casiraghi F, Centofanti L
Am J Physiol Endocrinol Metab. 2023; 325(5):E595-E609.
PMID: 37729025
PMC: 10874655.
DOI: 10.1152/ajpendo.00236.2023.
Kaneko S
touchREV Endocrinol. 2022; 18(1):10-19.
PMID: 35949358
PMC: 9354517.
DOI: 10.17925/EE.2022.18.1.10.
Pelle M, Provenzano M, Zaffina I, Pujia R, Giofre F, Luca S
Life (Basel). 2022; 12(1).
PMID: 35054422
PMC: 8779403.
DOI: 10.3390/life12010029.
Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract.
Morrow N, Hanson A, Mulvihill E
Front Cell Dev Biol. 2021; 9:703966.
PMID: 34660576
PMC: 8511495.
DOI: 10.3389/fcell.2021.703966.
The Role of cAMP in Beta Cell Stimulus-Secretion and Intercellular Coupling.
Stozer A, Leitgeb E, Pohorec V, Dolensek J, Krizancic Bombek L, Gosak M
Cells. 2021; 10(7).
PMID: 34359828
PMC: 8304079.
DOI: 10.3390/cells10071658.
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys.
Lu S, Chen M, Atangan L, Killion E, Komorowski R, Cheng Y
Cell Rep Med. 2021; 2(5):100263.
PMID: 34095876
PMC: 8149376.
DOI: 10.1016/j.xcrm.2021.100263.
Logical design of oral glucose ingestion pattern minimizing blood glucose in humans.
Fujii M, Murakami Y, Karasawa Y, Sumitomo Y, Fujita S, Koyama M
NPJ Syst Biol Appl. 2019; 5:31.
PMID: 31508240
PMC: 6718521.
DOI: 10.1038/s41540-019-0108-1.
Gut hormone polyagonists for the treatment of type 2 diabetes.
Brandt S, Gotz A, Tschop M, Muller T
Peptides. 2018; 100:190-201.
PMID: 29412819
PMC: 5805859.
DOI: 10.1016/j.peptides.2017.12.021.
Novel extrapancreatic effects of incretin.
Yamada Y, Tsukiyama K, Sato T, Shimizu T, Fujita H, Narita T
J Diabetes Investig. 2016; 7 Suppl 1:76-9.
PMID: 27186360
PMC: 4854509.
DOI: 10.1111/jdi.12495.
Alternative form of glucose-dependent insulinotropic polypepide and its physiology.
Fujita Y, Yanagimachi T, Takeda Y, Honjo J, Takiyama Y, Abiko A
J Diabetes Investig. 2016; 7 Suppl 1:33-7.
PMID: 27186353
PMC: 4854502.
DOI: 10.1111/jdi.12445.
Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report.
Knop F, Lund A, Madsbad S, Holst J, Krarup T, Vilsboll T
BMC Res Notes. 2014; 7:326.
PMID: 24885055
PMC: 4053292.
DOI: 10.1186/1756-0500-7-326.
GIP and GLP-1, the two incretin hormones: Similarities and differences.
Seino Y, Fukushima M, Yabe D
J Diabetes Investig. 2014; 1(1-2):8-23.
PMID: 24843404
PMC: 4020673.
DOI: 10.1111/j.2040-1124.2010.00022.x.
Physiology and emerging biochemistry of the glucagon-like peptide-1 receptor.
Willard F, Sloop K
Exp Diabetes Res. 2012; 2012:470851.
PMID: 22666230
PMC: 3359799.
DOI: 10.1155/2012/470851.
Adaptive selection of an incretin gene in Eurasian populations.
Chang C, Cai J, Lo C, Amigo J, Park J, Hsu S
Genome Res. 2010; 21(1):21-32.
PMID: 20978139
PMC: 3012923.
DOI: 10.1101/gr.110593.110.
A case-control analysis of common variants in GIP with type 2 diabetes and related biochemical parameters in a South Indian population.
Sugunan D, Nair A, Kumar H, Gopalakrishnapillai A
BMC Med Genet. 2010; 11:118.
PMID: 20673334
PMC: 2920866.
DOI: 10.1186/1471-2350-11-118.
The serendipitous origin of chordate secretin peptide family members.
Cardoso J, Vieira F, Gomes A, Power D
BMC Evol Biol. 2010; 10:135.
PMID: 20459630
PMC: 2880984.
DOI: 10.1186/1471-2148-10-135.
The role of incretins in glucose homeostasis and diabetes treatment.
Kim W, Egan J
Pharmacol Rev. 2008; 60(4):470-512.
PMID: 19074620
PMC: 2696340.
DOI: 10.1124/pr.108.000604.
Incretins, insulin secretion and Type 2 diabetes mellitus.
Vilsboll T, Holst J
Diabetologia. 2004; 47(3):357-366.
PMID: 14968296
DOI: 10.1007/s00125-004-1342-6.